颖泰生物
(920819)
| 流通市值：52.89亿 | | | 总市值：53.69亿 |
| 流通股本：12.08亿 | | | 总股本：12.26亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 1,201,314,356.87 | 1,115,897,036.2 | 1,137,037,084.93 | 1,477,858,022.1 |
| 应收票据及应收账款 | 1,363,029,983.69 | 1,427,417,547.3 | 1,494,132,966.17 | 1,322,423,951.84 |
| 应收账款 | 1,363,029,983.69 | 1,427,417,547.3 | 1,494,132,966.17 | 1,322,423,951.84 |
| 应收款项融资 | 111,920,081.67 | 111,528,592.29 | 67,881,964.9 | 77,016,480.84 |
| 预付款项 | 69,951,444.57 | 56,496,381.15 | 93,210,093.49 | 60,712,457.58 |
| 其他应收款合计 | 52,780,940.23 | 50,842,899.18 | 64,988,034.05 | 59,066,363.77 |
| 其中:应收利息 | 7,146,255.56 | 8,584,963.89 | 3,678,958.33 | 3,362,069.44 |
| 存货 | 1,553,012,289.72 | 1,550,020,658.03 | 1,669,389,969.1 | 1,784,645,559.6 |
| 合同资产 | 15,542,037.52 | 14,617,204.76 | 11,582,640.75 | 10,013,007.19 |
| 其他流动资产 | 186,665,838.23 | 222,996,839.22 | 204,156,567.95 | 190,223,959.55 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 4,555,194,741.41 | 4,549,817,158.13 | 4,742,379,321.34 | 4,981,959,802.47 |
| 非流动资产: | | | | |
| 长期股权投资 | 1,730,342,867.64 | 1,714,790,751 | 1,849,180,801.71 | 1,942,293,745.36 |
| 投资性房地产 | 110,484,442.28 | 111,432,214 | 113,108,225.69 | 113,385,584.57 |
| 固定资产 | 3,237,627,257.05 | 3,358,327,328.04 | 2,586,631,029.83 | 2,667,991,773.78 |
| 在建工程 | 849,790,830.08 | 785,637,868.13 | 1,627,163,128.69 | 1,567,774,190.25 |
| 使用权资产 | 37,000,916.47 | 37,484,433.07 | 45,248,853.44 | 45,732,370.04 |
| 无形资产 | 702,089,767.54 | 711,931,308.34 | 721,496,566.75 | 727,085,644.49 |
| 商誉 | 374,366,777.39 | 374,366,777.39 | 463,154,133.2 | 463,154,133.2 |
| 长期待摊费用 | 28,373,710.96 | 24,530,039.83 | 31,890,938.47 | 18,894,633.13 |
| 递延所得税资产 | 154,172,381.02 | 150,975,903.6 | 113,375,551.45 | 106,352,424.39 |
| 其他非流动资产 | 78,375,400.12 | 86,803,863.18 | 100,097,602.13 | 99,572,323 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 7,302,624,350.55 | 7,356,280,486.58 | 7,651,346,831.36 | 7,752,236,822.21 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 11,857,819,091.96 | 11,906,097,644.71 | 12,393,726,152.7 | 12,734,196,624.68 |
| 流动负债: | | | | |
| 短期借款 | 2,741,509,561.77 | 2,612,915,817.81 | 2,985,886,092.75 | 3,638,115,005.4 |
| 交易性金融负债 | - | - | 586,961.84 | 610,946.58 |
| 应付票据及应付账款 | 1,602,092,799.31 | 1,637,225,069.86 | 1,573,861,672.15 | 1,559,070,251.38 |
| 其中：应付票据 | 872,097,405.89 | 816,561,426.05 | 748,284,060.94 | 612,926,223.91 |
| 应付账款 | 729,995,393.42 | 820,663,643.81 | 825,577,611.21 | 946,144,027.47 |
| 预收款项 | - | 661,412.92 | - | - |
| 合同负债 | 52,676,357.5 | 124,024,872.33 | 117,486,696.01 | 47,339,083.8 |
| 应付职工薪酬 | 76,732,105.9 | 127,518,988.69 | 82,104,668.73 | 79,191,295.4 |
| 应交税费 | 25,171,187.88 | 46,835,279.24 | 35,610,497.3 | 55,732,066.17 |
| 其他应付款合计 | 129,666,580.54 | 234,143,395.29 | 240,462,465.53 | 358,234,875.51 |
| 应付股利 | - | - | - | 122,580,000 |
| 一年内到期的非流动负债 | 1,120,648,680.17 | 1,056,744,714 | 645,581,667.89 | 265,113,738.5 |
| 其他流动负债 | 1,992,100.33 | 6,954,058.29 | 10,605,241.36 | 4,693,269.12 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 5,750,489,373.4 | 5,847,023,608.43 | 5,692,185,963.56 | 6,008,100,531.86 |
| 非流动负债: | | | | |
| 长期借款 | 883,846,535.52 | 849,146,118.05 | 1,155,837,119.93 | 1,025,789,199.51 |
| 租赁负债 | 20,181,993.71 | 20,750,418.22 | 30,382,355.57 | 29,245,995.32 |
| 长期应付款 | 5,408,219.75 | 5,388,259.75 | 5,411,749.75 | 5,491,785.75 |
| 递延收益 | 99,747,251.01 | 99,153,947.52 | 64,899,454.82 | 65,669,552.42 |
| 递延所得税负债 | 48,368,380.56 | 48,709,444.34 | 47,589,748.23 | 49,621,562.22 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,057,552,380.55 | 1,023,148,187.88 | 1,304,120,428.3 | 1,175,818,095.22 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 6,808,041,753.95 | 6,870,171,796.31 | 6,996,306,391.86 | 7,183,918,627.08 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,225,800,000 | 1,225,800,000 | 1,225,800,000 | 1,225,800,000 |
| 资本公积 | 3,014,169,893.95 | 3,014,169,893.95 | 3,014,169,893.95 | 3,014,169,893.95 |
| 其他综合收益 | -86,944,565.71 | -98,624,732.47 | -132,862,393.54 | -95,207,163.08 |
| 专项储备 | 9,519,555.01 | 8,111,777.04 | 11,323,360.72 | 5,548,330.26 |
| 盈余公积 | 218,150,908.27 | 218,150,908.27 | 218,150,908.27 | 218,150,908.27 |
| 未分配利润 | 679,262,914.17 | 676,914,509.76 | 1,066,077,868.44 | 1,184,959,078.05 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 5,059,958,705.69 | 5,044,522,356.55 | 5,402,659,637.84 | 5,553,421,047.45 |
| 少数股东权益 | -10,181,367.68 | -8,596,508.15 | -5,239,877 | -3,143,049.85 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 5,049,777,338.01 | 5,035,925,848.4 | 5,397,419,760.84 | 5,550,277,997.6 |
| 负债和股东权益合计 | 11,857,819,091.96 | 11,906,097,644.71 | 12,393,726,152.7 | 12,734,196,624.68 |
| 公告日期 | 2025-04-18 | 2025-04-18 | 2024-10-25 | 2024-08-19 |
| 审计意见(境内) | | 标准无保留意见 | | |